L atex allergy is a serious public health issue with wide boundaries and broad workplace implications. Individuals of any age, of any geographic location (rural or metropolitan), admitted with any clinical diagnosis or from any workplace setting in which there is natural rubber latex exposure may develop latex allergy. According to V.S. Department of Health and Human Services [VSDHHS] (1997) :
The amount of latex exposure needed to produce sensitization or an allergic reaction is unknown; however, reductions in exposure to latex proteins have been reported to be associated with decreased sensitization and symptoms.
Prevalence studies have shown an increase from 2.4% in the 1980s to 8% to 17% in 1997 in latex allergy in certain high risk groups such as health care workers (VSDHHS, 1997; Kelly, 1995a; Yassin, 1994) . Variations of prevalence data among all populations are probably a result of different amounts or types of exposure (e.g., contact, airborne) and whether questionnaires or laboratory test methods were used for estimating latex sensitization or clinical allergy. Prevalence data from other at risk groups are also reported : patients with spina bifida (18% to 73%) , paramedics (10%) (Safadi, 1996) , housekeepers (8%) (Sussman, 1995) , industrial workers (11%), and the general population (1% to 6%) (VSDHHS, 1997) . gy, especially with occupational asthma, may not be able to continue to work in a health care environment and may have to deal with years of chronic illness and the potential for episodic, one time anaphylactic events in or outside health care settings (Bernstein, 1997; Charous, 1994a Charous, , 1994b U.S. Department of Labor, 1999) .
This same employee has the potential to become a patient and seek health care frequently in the same facility. The question often asked is: "Can these individuals be treated successfully as patients in the same facility in which they are unable to work without experiencing allergic reactions?" An equally pertinent question currently being asked of occupational health department staff is: "Are you or could you hire a person with a Type I latex allergy?" The ability to provide a positive answer to these timely, quality risk questions is essential and depends on the careful development of workplace prevention strategies for the management of latex allergy.
This article describes research based, facility wide, multidimensional strategies or interventions to support the goal of a latex safe environment and the role of the nurse in attainment of that goal.
SELECT A CHANGE AGENT TO LEAD THE MULTIDISCIPLINARY TEAM
The development of overall policies or guidelines for facility wide prevention management, reasonable accommodations, or individual work environment modifications for employees with history or risk of latex allergy should be research based and directed by a multidisciplinary committee. The occupational health nurse can be a positive "change agent" as a key member of that committee to ensure workplace issues are addressed. Practice changes or work environment modifications require all team members to be able to articulate, in formal and informal settings, clear goals and rationale supported by research data. This aids in diminishing resistance to change and assist in achieving stakeholder "buy in" (Manuel, 1999) .
A LATEX SAFE OR LATEX MINIMIZED ENVIRONMENT
Two major overall management approaches can be used in relation to the issue of latex allergy. The approach adopted by the multidisciplinary team will influence the goal or type of implementation strategies developed. The first is a safety/public health or primary prevention approach to protecting and promoting the health of employees. This approach protects those at risk but not yet symptomatic.
The other approach is secondary prevention, which includes preventing escalation of symptoms in individuals already affected, crisis management of an acute anaphylactic event, or ongoing treatment. This may involve evaluation of presenting symptoms and referral for individuals presenting with symptoms of illness or an established diagnosis. Secondary interventions include symptomatic treatment, changes in work sites, accommodations or removal of the employee from the work environment. Both primary and secondary prevention approaches have their own merit in the management of latex allergy in the workplace. JUNE 2000, VOL.48. NO.6 A latex safe, latex minimized, or latex reduced environment is often a goal adopted by multidisciplinary committees combining both approaches ofprimary and secondary prevention.
A latex safe, latex minimized, or latex reduced environment is often a goal adopted by multidisciplinary committees combining both approaches of primary and secondary prevention. One facility wide definition of latex safe is to reduce or minimize contact and aerosolized latex allergen exposure that leads to potential immune sensitization or initiation or continuation of symptoms for employees, patients, and visitors. This broader goal benefits individuals with confirmed or diagnosed latex allergy or asymptomatic individuals at risk for development of the allergy.This goal can serve as the overall objective or aim to guide a multidisciplinary team in the development of management strategies for both patients and employees.
RESEARCH BASED PREVENTION STRATEGIES
Such prevention strategies can provide the potential framework to form successful, reasonable accommodations for clients who may report to an occupational health service with symptoms or a clinical history with potential risk of latex allergy. They include: • Using a screening questionnaire to recognize potential risk factors of latex allergy or identify symptoms indicative of latex allergy for an individual employee. • Documenting need for physician referral for further evaluation of symptoms and possible diagnosis. • Developing facility wide product selection or standardization to reduce allergen exposure and consolidation of inventory. • Using work environment controls which include recognition, elimination, or monitoring of potential sources of contact and aerosolized natural rubber latex contamination particularly through facility wide glove use changes.
STANDARDIZED SCREENING QUESTIONNAIRE
Occupational health nurses need a thorough understanding of latex allergy to formulate a standardized triage plan, assessment algorithm, or questionnaire to recognize and document the potential risk or history of symptoms of latex allergy for each individual employee. The goal is to successfully refer an employee to a physician for a confirmed diagnosis when appropriate, accommodate or relocate within the work setting, or provide symptomatic treatment for each of these clients. Screening questions generally document a known, diagnosed latex allergy, symptoms, or reactions when in contact with natural rubber latex at work or during recent medical or dental proce-dures, regular or frequent natural rubber latex exposure occupationally or medically, and an atopic history (Gliniecki, 1998; Miller, 1998; .
In the author's experience, these questionnaires have been used routinely at post-offer interviews for new employees or at the time the employee presents to the health service with reactions related to latex exposure. However, anecdotal reports to the author from numerous hospitals have indicated an increasing number of occupational health units are instituting standard facility wide questionnaires to all employees to identify risk factors and positive history of symptoms of latex allergy. Yearly updates are conducted to document elimination or progression of any symptoms.
The ongoing challenge is that this type of employment inquiry needs to be voluntary according to the Americans With Disabilities Act (ADA Regulations 29 CPR Part 1630). The results should be used to assist workplace accommodation, not job termination. Frequently asked questions the author receives include:
• "Now what do I do with the information gained from the questionnaire that this employee is at risk for development of latex allergy if our facility has not made any product or environmental changes?" • "Can individual counseling and documentation in the records occur without employment jeopardy?" Latex Allergy Cycle Exposure. A clear understanding of the pathophysiology of the phases of an allergic reaction aids in understanding the type of questions to ask on a screening questionnaire (see Figure 1 ). Immediate (Type I) allergic reactions to natural rubber latex are mediated through antilatex immunoglobulin E (lgE) antibodies. Exposure to latex proteins can occur either through the skin, respiratory tract, or mucosal/serosal membranes. Primary immune sensitization occurs when plasma cells produce IgE antibodies specific for one or more of the nearly 60 IgE producing latex antigens. These IgE antibodies attach to mast cells located in various parts of the body.
At some subsequent reexposure (see Figure 2 ) to latex, which may be hours, days, weeks, or months away, the antigen and antibody connect or bind and cause the release of cell mediators which triggers the onset of clinical latex allergy symptoms (Hamann, 1993; Ownby, 1995) . Once clinical latex allergy symptoms occur, no cure or desensitization is currently available.
Immune Sensitization. According to Beezhold (1997) , primary sensitization is the development of immunologic memory by exposure to a given natural rubber latex antigen. Individuals develop sensitivity or clinical latex allergy after they develop immunologic memory to latex antigens. Immune sensitization and the onset of clinical latex allergy are two separate events which mayor may not occur simultaneously.
Clinical Latex Allergy. The latex allergy clinical presentation is variable (see Table 1 ). Clinical presentation depends on the person's sensitivity level, type of work, route of product exposure (i.e., skin contact, mucosal, or 280 inhalation), and amount of allergen level in the product (Holzman, 1993; Kelly, 1996a; Ownby, 1995) . Some individuals will have only Type IV allergic contact dermatitis or only Type I systemic latex allergy. The same person can also have both allergic contact dermatitis (Type IV) and a systemic (Type I) latex allergy. An unpredictable progression of symptoms can also occur with continued contact or aerosolized exposure. Forty to 50% of individuals may have contact dermatitis for months or years and then have a rapid advance of symptoms to contact urticaria or to laryngospasm, asthma, or anaphylaxis (Charous, 1994b; Kelly, 1996a) . Others never have allergic contact dermatitis and begin with contact urticaria and may progress to respiratory symptoms with continued exposure (Charous, 1994b; Hunt, 1995) . However, more importantly, as much as 30% of clients may not have any preliminary symptoms and, with some occupational or medical exposure, have an anaphylaxis as their first reaction (Granady, 1995; Yassin, 1998) . Kelly (1996b) reported a sensitized health care worker who continues to be exposed to natural rubber latex may develop occupational asthma. The prevalence of latex induced occupational asthma is reported to be 2.5% to 6% within the past 5 years (Phillips, 1999) . Very small amounts of protein may induce a symptomatic response in someone with latex sensitivity.Once established, the occupational asthma may progress and persist even after strict avoidance in the work setting. Symptoms may be triggered by nonspecific stimuli and pulmonary function may remain permanently impaired even after the employee leaves the work setting (Charous, 1994a; Kelly 1996b) .
Risk Factors
Health history obtained with a questionnaire or interview also may reveal factors considered as increased risk for the development of latex allergy. These are frequent, regular, or prolonged natural rubber latex exposure occupationally or medically with early or multiple surgical procedures or chronic bladder catheterization. Also at risk are atopic individuals especially, those with asthma, rhinitis (hayfever), and eczema (Ownby, 1995; . Individuals at high risk of developing IgE mediated latex allergy are atopic, highly exposed to natural rubber latex, or both (Kelly, 1998) . A study of more than 500 subjects reported the atopic person is preferentially sensitized by frequent contact with latex gloves. It was noted, "although atopy and frequent exposure to latex are independent risk factors for sensitization to latex, they also act synergistically, so the cumulative risk is very high (36.4%)" (Moneret-Vautrin, 1993) .
Food Cross Reactivity. The major cross reactive foods identified are banana, avocado, kiwi, and chestnut. Other foods moderately associated with latex allergy reactions are apricot, papaya, passion fruit, pineapple, peach, nectarine, plum, cherry, melon, fig, grape, potato, tomato, and celery . The latex sensitivity may appear before, at the same time, or after the development of the food sensitivity. Plant proteins with structural homology to latex proteins may predispose to food allergy, which gives importance to gaining a careful his- 
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tory of food allergy in anyone suspected of latex allergy (Beezhold, 1996) .
Diagnosis. The first step in diagnosis of Type IV contact dermatitis or Type I latex allergy continues to be history of symptoms in relation to exposure to natural rubber latex products (Granady, 1995) . Medical evaluation to establish a diagnosis of a suggestive clinical history, with or without established high risk factors, includes an attempt to confirm the history with laboratory tests (Hamilton, 1998) .
Type N Allergic Contact Dermatitis. Individuals with hand dermatitis and exposure to natural rubber latex products need documentation of sensitivities to rubber additives by patch testing. Patches with appropriate levels of chemicals are taped to the client's back for 48 to 96 hours and interpreted according to standardized techniques . A positive reaction to a particular chemical can alert caregivers to investigate latex and nonlatex glove use and change to a glove without that particular additive. Upon written request, manufacturers can supply information about residual chemical additives, dyes, or accelerators used in the production of specific gloves to aid the occupational health nurse in selecting an alternative product.
Type I LatexAllergy. Diagnostic testing to confirm Type I systemic latex allergy includes in vitro and in vivo methods with differing levels of sensitivity. In vitro immunoassays are designed to measure IgE antibody in serum and are used to confirm results of skin testing, used when skin testing is considered too risky for potential anaphylaxis or when skin testing is not available . Current commercial latex specific IgE assay methods include the enzyme linked immunoabsorbent assay (ELISA), the radioallergosorbent test (RAST) and ImmunoCAP System (Pharmacia-Upjohn Diagnostics Division, Kalamazoo, Ml) and the latex AlaSTAT (Diagnostic Products Corporation, Los Angeles, CA) .
The in vitro immunoassays have been shown to be 90% to 96% sensitive or reliable (Kellet, 1997) . Because of the less than 100% sensitivity, a negative latex specific in vitro IgE test does not rule out a diagnosis oflatex allergy nor does the value of the positive serological test predict the severity of a potential allergic reaction. There are clients with negative or asymptomatic clinical histories with a positive immunologic test and some with a significant positive clinical history with a negative test (Hamilton, 1998; Kellet, 1997) . Negative skin prick testing or serologic testing conducted shortly after an acute allergic reaction might also reflect a "false negative" because of the immunologic refractory period (Charous, 1994a) .
The in vivo method of skin prick testing with latex allergen extracts is considered the most sensitive or reliable means of detecting IgE antibody to latex proteins. No commercially available FDA approved standardized reagent currently exists (Hamilton, 1998) . Research centers and some allergists prepare their own reagent by using extractions from latex gloves or raw latex sap. The variability in the allergenic protein levels of these glove extracts may result in anaphylactic reactions or false negative results . The American College of Allergy, Asthma and Immunology Guidelines recommend skin prick testing with nonstandardized 284 latex extract must be performed by a qualified specialist with nonlatex resuscitative equipment and medication available to manage anaphylactic reactions. Currently new reagents are being researched to improve the diagnostic value and safety of skin prick testing (Hamilton, 1998) .
FACILITY-WIDE PRODUCT SELECTION TO REDUCE EXPOSURE Protection Recommendations
The American College of Allergy, Asthma, and Immunology recommends latex avoidance precautions for anyone with a positive latex skin test or serologic test. Precautionary latex avoidance measures for medical treatment are recommended empirically by some physicians for the high risk group of health care workers with positive history (symptoms with natural rubber latex contact) even without confirmatory laboratory tests (Yassin, 1994) . Brown (1998) reported that of 168 anesthesiologists tested with a skin prick test, 12.5% were positive for the anti-latex antibody. Of those who were positive with the IgE antibody, only 2.5 % were symptomatic if exposed to natural rubber latex. Ten percent had positive IgE antibody, but were not yet symptomatic. It is those 10% who are positive IgE, but are clinically asymptomatic, who may benefit most by an overall reduction in health care environment exposure (Brown, 1998) .
Product Avoidance
At present, the primary mode of treatment for latex allergy is avoidance, preferably by removal of natural rubber latex products (especially powdered gloves) from the environment. The caregiver must remove all natural rubber latex products from the patient environment and substitute nonlatex products in a cart or kit for safe access according to most latex allergy patient policies.
Product Standardization
Standardization of some regularly used products to nonlatex eliminates double inventory and prevents inadvertent use of a natural rubber latex product. Computer generated or hard copy, manufacturer verified lists of all product inventories, stating whether the product has natural rubber latex or not, is critical to support protocols or policies. The FDA mandated in a final ruling, effective September 30, 1998, all medical products that may come into human contact are labeled: ''This product contains dried or natural rubber latex" (FDA, 1997) . This will aid in product identification for the clinician, while old inventory is being replaced with the newly labeled inventory.
Product Inventories
Occupational health policies to assist employees in workplace accommodations need to include a review of unit and facility product inventories as well. The key factors to consider for employees are whether the product is molded or dipped with powder and if the employee will come into direct contact or indirect contact with product or not. If products are powdered, there is potential indirect respiratory exposure. The major powdered products are gloves (e.g., examination, sterile, those in medical kits or trays), tourniquets, some catheters, and balloons. Molded products such as syringe plungers, multidose vial stoppers, and blood pressure cuff tubing generally have lower allergen levels than dipped products and do not contribute to aerosolization of latex proteins .
Medical Kits
A study at Mayo Medical Center (Jones, 1998) found allergen contents of the gloves in 87 sterile kits and trays ranged from nondetectable to 36,000 allergen units/mL. For the RAST inhibition assay expressed in allergen units/mL, the following scale has been used for interpretation of results: ideal, 1 to 14; low, 15 to 99; medium, 100 to 999; and high, more than 1000 (Beezhold, 1997) . Often, medical kit packaging has not indicated whether or not the gloves were powdered. If gloves are powdered, allergen coated powder can be distributed to other kit components or dispersed in the air. This can increase the chances of triggering an allergic response in a latex sensitive patient or employee (Jones, 1998) . Facilities with latex allergic employees can consider ordering medical kits or trays containing only nonlatex gloves or have no gloves in them. Non-powdered latex or nonlatex gloves can then be added at the time of use.
CONTROLLING THE WORK ENVIRONMENT
Gloves An estimated 22.0 billion surgeons' and patient examination gloves were used in the United States in 1997 as a response to OSHA regulations requiring barrier protection for patients and employees exposed to bloodborne pathogens (FDA, 1999) . Gloves are the key natural rubber latex product exposing workers to latex protein antigens because of high volume use in both health care and non-health care industries. Contact and inhalation exposure can occur. Frequent or prolonged occupational or medical exposure to natural rubber latex is the major risk factor in the development of latex allergy (AAAAI and ACAAI Joint statement, 1997; FDA, 1999; U.S. Department of Labor, 1999).
All latex gloves, even low allergen, nonpowdered gloves, have measurable levels of allergenic proteins, and susceptible individuals produce specific IgE antibody to these natural rubber latex proteins (AAAAI and ACAAI Joint Statement, 1997; Sussman, 1998; U.S. Department of Labor, 1999) . According to Sussman (1998) , "A reduction in respiratory latex allergen would result not only in a decrease in sensitization, but also a reduction in the incidence of occupational asthma."
Contact Transfer of Allergens
Health care workers wearing latex gloves not only are exposing themselves, but become the main vehicle to expose patients to natural rubber latex antigens. Beezhold (1994) studied this dual transfer of protein allergens from latex gloves. This study found "latex protein absorption through the skin is postulated as the major route of occupational exposure for health care workers." Beezhold (1994) also concluded: JUNE 2000, VOL.48, NO.6 Hands should be washed immediately after removing gloves to eliminate latex proteins from the skin and prevent latex protein transfer to mucous membranes of the eyes, nose, or mouth. Hand washing after glove removal also prevents transfer of latex proteins to other surfaces (e.g., door knobs, telephones, charts, instruments) where they can be contacted by latex sensitive individuals.
The latex gloved (especially examination gloved) hand can transfer protein allergens to these surfaces as well.
Airborne Transfer of Proteins
Glove powder, namely cornstarch, is used as a donning agent in up to 90% of current gloves produced in the United States. Glove powder also contributes to adverse health effects such as foreign body reactions resulting in inflammation, granulomas, and adhesions of peritoneal tissues after surgery and can become a vector or transport medium for latex proteins (Beezhold, 1992; Edlich, 1997; FDA, 1999) . Airborne latex proteins bound to this powder may become inhaled antigens and can inoculate surgical tissue and contaminate suture material, instruments, drapes, or sponges. Latex dust can remain airborne for up to 2 hours and has also been shown to contaminate laboratory coats, surgical scrubs, upholstered furniture, drapes and carpet, and travel through ventilation systems within a building (Charous, 1998) . Swanson (1994) studied latex aeroallergens in various worksites using area and personal breathing zone air samplers. In 11 areas where powdered latex gloves were frequently used, latex aeroallergen concentrations were 13 to 208 nglm 3 , and in areas where powdered latex gloves were never or seldom used or where powder free or vinyl gloves were used, concentrations ranged from 0.3 to 1.8 ng/mt, To interpret the scoring system of aeroallergen content in a room using the LEAP assay (Guthrie Research Institure, Sayre, PA): low, less than 10 ng/m'; medium, 10 to 50 ng/m'; high more than 50 ng/rn> (M. Swanson, personal communication, 1996) . Exposure was found likely to occur when gloves are changed and as a result of resuspension from reservoirs of powder in the room and on clothing. Even the special orthopedic surgical suite, with 225 changes of air per hour, was found insufficient to wash out or dilute the aeroallergens from the air (Swanson, 1994) .
Workplace Control of Aerosolized Latex
A combination of nonlatex, non-powdered or low allergen, non-powdered latex examination, sterile, and utility glove choices historically have become the primary proactive strategy adopted by numerous hospitals and clinics throughout the U.S. to attempt to create a latex minimized or latex safe environment (ACAAI and AAAAI Joint Position Statement, 1997; USDHHS, 1997; U.S. Department of Labor, 1999) .These glove changes will meet the basic overall goal to minimize both contact and aeroallergen latex allergen exposure that may lead to primary sensitization or continuation of symptoms in those who already have latex allergy.
It is estimated that examination glove usage in a , health care facility comprises approximately 96% to 99% of total glove use, and conversion to nonlatex for these non-sterile gloves can greatly affect levels of latex antigens in the environment (Phillips, 1999) . Facility wide changes, especially to sterile surgeons' nonlatex gloves, have met with resistance in some areas because of availability of product, concerns about protective features, tactile quality, and cost (Phillips, 1999) . Allmers (1998) found staff with respiratory symptoms and natural rubber latex specific IgE antibodies, identified with skin prick testing, worked in rooms with a detectable allergen load. After an intervention eliminating all powdered latex gloves from the workplace and giving latex free gloves to sensitized workers, aeroallergen loads fell below detectable level in 24 hours, and six of the seven sensitized workers had a significant decrease in IgE antibody concentrations and medication use on follow up. Most significant was the glove change intervention permitted some sensitized workers to remain on the job.
GLOVE INTERVENTIONS FOR SENSITIZED WORKERS TO REMAIN ON THE JOB

Combined Changes: Low Allergen, Non-Powdered, and Nonlatex Gloves
Nonlatex Glove Changes
Current research at Johns Hopkins has shown a decrease in symptoms and evidence of diminished skin prick test size when clients allergic to latex practice strict latex avoidance. Hamilton (1999a) reviewed 11 identified IgE antilatex, skin prick test positive health care workers. Of the 11 subjects, 4 were initially symptomatic with rhinitis, conjunctivitis, asthma, or anaphylaxis. Seven were sensitized but asymptomatic. After 9'h months of personal and environmental latex glove avoidance, the 4 symptomatic health care workers lost allergic skin and respiratory symptoms associated with latex product use. Serum IgE anti latex levels per the skin prick test as a group decreased. At 15 months, 4 health care workers lost all detectable laboratory sensitivity. Hamilton (1999b) reported Johns Hopkins is transitioning to a synthetic glove environment and will continue to monitor the above group for a continued reduction in sensitivity as they avoid exposure. The facility has replaced latex examination gloves with long cuff stretch vinyl and nitrile gloves. They are evaluating quality sterile synthetic surgeons' gloves in their operating rooms as well. According to Hamilton (1999b) :
There is some data to suggest that latex allergic health care workers can work safely in an environment where only powder free latex gloves are used if the latex allergic person uses only synthetic (nonlatex). However, we do not believe this a viable option for Johns Hopkins because we cannot prove to ourselves that the low but detectable levels of allergen remaining in the powder free latex gloves do not continue to sensitize our workers and patients.
These changes have minimal cost impact because of volume purchasing, will minimize the risk for de novo sen-sitization of predisposed atopic health care workers, and will address the difficulty in trying to accurately measure low nglmL levels of allergenic protein in environments to define a safe level (Hamilton, 1999b) .
MonitorFacility Wide Changes
If individuals with latex allergy are employed in a facility, the entire environment in the facility must be evaluated for stability or control of airborne latex exposure to provide the potential for safe, reasonable accommodation for workplace modifications. With only unit specific air control modifications there is the possibility that some employees will not be successful with relocation and will require permanent removal from the workplace. It is important to recognize that employees often are not able to work in only one unit. They float to other units in down times, walk through the facility to lunch, take patients to the x-ray department, or pick up patients in the emergency department. Examples of uncontrolled powdered latex exposure include: • A paramedic wearing powdered latex gloves who brings patients into the emergency department on gurneys. • A physician who leaves the operating room in which powdered latex gloves have been used. • A health care worker who does not change scrubs and performs rounds. • A laboratory technician who walks through the facility with latex tourniquets and powdered latex gloves.
OSHA UPDATE
The OSHA recommends risk reduction strategies to reduce "potential development of allergy by reducing unnecessary exposure to NRL [natural rubber latex] products for all workers" (U.S. Department of Labor, 1999) . The B100dborne Pathogens Standard requires gloves be worn when it is reasonably anticipated that hand contact may occur with blood, other potentially infectious materials, mucous membranes, non-intact skin or contaminated items or surfaces, and when performing most vascular access procedures (OSHA, 1987) . The OSHA does not mandate the type of glove material that must be worn (i.e., latex, synthetic). Instead, OSHA clarifies: "Gloves made of NRL as well as synthetic materials have been cleared for marketing as medical gloves by the FDA and can be used effectively for barrier protection against bloodborne pathogens" (U.S. Department of Labor, 1999) .
It is also recommended that individuals with a latex allergy and those with no potential for bloodborne exposure such as food handlers or general housekeeping eliminate the use of natural rubber latex gloves and use a synthetic alternative to reduce exposure. The use of latex gloves is a discriminate choice. If the choice is made to use a natural rubber latex glove, it is recommended the glove be low allergen and non-powdered (AAAAI and ACAAI Joint Statement, 1997; USDHHS, 1997; U.S. Department of Labor, 1999) .
INFORMED CHOICES
The challenge for a multidisciplinary committee within a facility in the current market of more than 198 glove manufacturers is to make informed or discriminate glove choices which will allow individuals to follow the above recommendations from national agencies and professional groups and to allow individuals to: • Know the kind of glove (material) they are wearing. • Know if that glove is appropriate in durability, barrier, and material for the work. • Know the end use time, amount of torque, and twisting or instrumentation required for the work. • Know the risk factors and symptoms of latex allergy. • Know if the glove they are wearing may be a potential danger to themselves or their colleagues.
Choice Criteria
Informed, discriminate, and appropriate glove choices begin with the development of a "glove formulary." This can aid a multidisciplinary committee in the process of data collection for the selection of standardized glove choices and the consolidation of inventory to decrease cost for the employer. Written specific data from manufacturers to compare varying gloves features can become a template to assure careful product selection. Specific data about barrier quality, allergen and powder content, chemical additives, glove material information, and added value quality standards are common features of a glove formulary (see Table 2 ) (American Society for Testing and Materials, 1999; FDA, 1996; Korniewicz, 1997; Witmeyer, 1997) .
NATIONAL GLOVE MARKET
The current billion dollar medical glove market is changing to meet consumer needs.· Natural rubber latex gloves comprise 90% of the market, with nonlatex gloves at 10%. The share of nonlatex vinyl and synthetic polymers is expected to increase to more than 20% of the market. Sixty-five percent of current gloves are powdered but it is expected that by the end of the year 2000, 60% of all gloves may be powder free (FDA, 1999) . The FDA (1999) states: "The market share of powdered gloves is decreasing rapidly as facilities gain awareness of the potential adverse health effects associated with natural rubber latex protein allergens."
The FDA (1999) has proposed new regulations to reclassify latex and synthetic gloves as Class II medical devices, more clearly define categories of gloves, recommend protein and glove powder limits, and require new label caution statements including protein and powder levels. The FDA (1999) states this rule is intended to reduce the adverse health effects from allergic and foreign body reactions caused by the natural latex protein allergens and glove powder found on surgeon's and patient examination gloves and to reduce the adverse health effects from defects in the barrier integrity and quality of surgeon's and patient examination gloves.
COST AS A RISK /BENEFIT DECISION
A facility considering a glove conversion can analyze cost impact by comparing the direct cost of gloves purchased against the cost of risk avoidance and employee sensitization, impairment, or disability. Phillips ) JUNE 2000 reported an analysis comparing the cost of a latex safe approach defined by changing to nonlatex gloves facility wide with that of continued latex glove use. They identified the level of worker disability required to make the latex safe approach financially preferable to the institution. A break even point was established for three facilities: a tertiary hospital, a community hospital, and a clinic. When only glove costs were considered, the data indicated the latex safe approach was more expensive for each facility than continued latex glove use. However, in all three facilities 1% or fewer of those at risk for the development of latex allergy would have to become fully disabled or fewer than 2% would have to become partially disabled for the continued use of latex gloves to exceed the cost of the latex safe approach. They concluded that health care facilities, regardless of size, are likely to benefit financially from becoming latex safe even if latex related disability levels are extremely low (Phillips, 1999) .
CONCLUSION
The development of overall policies or guidelines for facility wide prevention management, reasonable accommodations, or individual work environment modifications for employees with history or risk of latex allergy should be research based and directed by a multidisciplinary committee. A latex safe, latex minimized, or latex reduced goal can combine both approaches of primary and secondary prevention to reduce or minimize contact and aerosolized latex allergen exposure leading to potential immune sensitization or initiation or continuation of symptoms for employees, patients, and visitors. This approach combines the interventions of a screening questionnaire to recognize potential risk factors or history of latex allergy in individual employees; documentation of a referral to a physician for diagnosis; standardization of facility wide general product selection; and work environment controls by discriminate, appropriate, and informed glove choices to meet the management goal.
According to Klaus Junghanns, Guest Editor of the European Journal of Surgery's issue, "Glove Powder-
The Hazards Which Demand a Ban" (1997):
The potential costs of ignoring latex allergy (litigation, retraining, restructuring hospital environments, compensation) are much higher than those incurred by changing to low allergy powder free gloves. In fact, changing a hospital to a latex safe or latex free glove can even be cost saving, when combined with scrutiny of all glove purchasing policy. Powdered latex gloves clearly have the detrimental effects of adhesion formation, allergy and infection. We have accumulated enough scientific data to conclude glove powder has to be banned. This is necessary for the better health of our patients, and of our hospital colleagues. The adoption of powder free non latex gloves should ultimately contribute substantial savings for hard pressed health care budgets. • Chemicals that can be used safely with glove material.
• FDA (1999) and ASTM (1999) Review latex and non-latex glove information for minimal to absent chemical accelerators, especially Thiurams, Carbomates, Mercaptobenzothiozoles (MBTs).
• Note the differences in types of material : latex, vinyl, nitirile, neoprene, polyisoprene, and elastryn. Each has specific characteristics and applications for use. • Note if glove is smooth or textured , thickness of fingers, palm, and cuff.
• Piloting for "in use" preferences allows choice of the glove that best fits the work.
Good manufacturing practices require quality assurance programs appropriate for the device manufactured (21CFR Part 820). Many provide education. 3. AAOHN Journal 2000; 48(6) , 278·290.
Facility-wide goals should combine primary and secondary prevention approaches to reduce or minimize contact and aerosolized natural rubber latex exposure for clients, employes, and visitors.
Potential immune sensitization or continuation of symptoms of latex allergy can be reduced by using screening questionnaires to recognize potential risk factors or history of latex allergy; documentation of a referral to a physician for diagnosis; standardization of facility-wide general product selection; and work environment controls by discriminate, appropriate, informed glove choices.
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